Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

September 13, 2011 | Corporate News | English

Tecan to present at UBS Global Life Sciences Conference

Tecan to present at UBS Global Life Sciences Conference

 

Männedorf, Switzerland, September 13, 2011 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the UBS Global Life Sciences Conference on Tuesday, September 20, 2011 in New York City.


The investor presentation will begin at 08:30 a.m. EDT (14:30 p.m. CET) and will be webcast live. The webcast may be accessed under the “Investor Relations” tab of Tecan’s website www.tecan.com.

A replay of the webcast will be available shortly following the presentation and will remain available for at least four weeks.

 

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).
 

 

For further information

Tecan Group

Martin Braendle
Head of Corporate Communications &
Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com

 

Downloads: